|
Report Date : |
20.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
MORVEL LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
25, Jawahar Nagar Society, Visnagar, District Mehsana –
382 010, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
16.05.1983 |
|
|
|
|
Com. Reg. No.: |
04-6187 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.1.300 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231GJ1983PTC006187 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
AHMM03523C |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals. |
|
|
|
|
No. of Employees
: |
50 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (27) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 11000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track record. There
appears loss recorded by the company. However, trade relations are reported
to be fair. Business is active. Payments are reported to be slow but correct.
The company can be considered for business dealing with some caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Mr. Kalpesh Patel |
|
Designation : |
Accounts Department |
|
Contact No.: |
91-2762-255041 |
|
Date : |
14.08.2012 |
LOCATIONS
|
Registered Office : |
25, Jawahar Nagar Society, Visnagar, District Mehsana –
382 010, |
|
Tel. No.: |
91-2762-255041/42 |
|
Fax No.: |
91-2762-240145 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
400 sq. ft. |
|
Location : |
Owned |
|
|
|
|
Factory / Marketing Office : |
251 G.I.D.C. Estate, Near |
|
Tel. No.: |
91-2762-255041 / 255042 |
|
Fax No.: |
91-2762-240145 |
DIRECTORS
As on 26.09.2011
|
Name : |
Mr. Rikinbhai B Patel |
|
Designation : |
Director |
|
Address : |
25, Jawahar Nagar Society, |
|
Date of Birth/Age : |
31 Years |
|
Experience : |
Engineering |
|
Date of Appointment : |
08.09.2004 |
|
DIN No.: |
01066258 |
|
|
|
|
Name : |
Mrs. Minaxiben K. Patel |
|
Designation : |
Director |
|
Address : |
Bharatnagar Society, |
|
Date of Birth/Age : |
30 Years |
|
Qualification : |
B. Ed. |
|
Date of Appointment : |
16.07.2003 |
|
DIN No.: |
02370944 |
KEY EXECUTIVES
|
Name : |
Mr. Kalpesh |
|
Designation : |
Accounts Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 26.09.2011
|
Names of Shareholders |
|
No. of Shares |
|
Patel Rikin |
|
2669 |
|
Patel Shardaben |
|
1690 |
|
Patel Meenaben |
|
600 |
|
Patel Gangarambhai |
|
600 |
|
Patel Jayantibhai |
|
500 |
|
Patel Baldevbhai |
|
410 |
|
Patel Parulben |
|
400 |
|
Patel Jayesh |
|
390 |
|
Patel Ashish |
|
361 |
|
Patel Khemabhai |
|
220 |
|
Patel Amratbhai |
|
210 |
|
Patel Darshit |
|
210 |
|
Patel Amratbhai |
|
200 |
|
Patel
Tribhovandas |
|
200 |
|
Patel
Arvindkumar |
|
200 |
|
Patel
Dashrathlal |
|
200 |
|
Patel Rameshbhai |
|
200 |
|
Patel
Dhavalkumar |
|
200 |
|
Patel Shanibhai |
|
200 |
|
Patel Lalitaben |
|
200 |
|
Patel Gangaben |
|
200 |
|
Patel Sagarbhai |
|
200 |
|
Patel Jyosnaben |
|
200 |
|
Patel Sureshbhai |
|
200 |
|
Patel Ramilaben |
|
200 |
|
Patel Mohanbhai |
|
200 |
|
Patel
Narayanbhai |
|
200 |
|
Patel
Jayantibhai |
|
200 |
|
Patei
Gordhanbhai |
|
200 |
|
Patel Babubhai |
|
200 |
|
Patel Gopalbhai |
|
200 |
|
Patel Revabhai
HUF |
|
200 |
|
Patel
Narottamdas HUF |
|
200 |
|
Patel
Prahladbhai |
|
200 |
|
Patel Maganbhai |
|
180 |
|
Patel
Jushumatiben |
|
100 |
|
Patel Rinku |
|
20 |
|
Patel Renu |
|
10 |
|
Patel Kamalbhai |
|
10 |
|
Patel
BharatKumar |
|
10 |
|
Patel
Hasmukhbhai |
|
10 |
|
|
|
|
|
Total |
|
13000 |
Equity Share Break up (Percentage of Total Equity)
As on 26.09.2011
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of Pharmaceuticals. |
|
|
|
|
Products : |
Veterinary Injections Products
·
Gentamicin Injections ·
Oxytetracycline
Injections ·
Neomycin Injections ·
Enrofloxacin Injections ·
Ceftriaxone Injections ·
Cefoperazone Sodium and
Sulbactum Sodium Injections ·
Amoxycillin and
Cloxacillin Injections ·
Ampicillin and
Cloxacillin Injections ·
Trimethoprim and
Sulphamethoxazole Injections (2) Veterinary
Analgesics Injection ·
Dicyclomine
Hydrochloride Injections ·
Meloxicam Injections ·
Phenyl Butazone and
Sodium Salicylate Injections ·
Analgin Injection (3) Veterinary
Anaesthetics Injections ·
Lignocaine
Hydrochloride and Adrenaline Bitrate Injection ·
Triflupromazine
Hydrochloride Injections (4) Veterinary
Vitamin Injections ·
Vitamin A Injections ·
Vitamin AD3E Injections ·
Crude liver extract with
vitamin B-Complex Injections ·
Vitamin B-Complex
Injections ·
Vitamin B1B6B12
Injections (5) Veterinary
Minerals Injections ·
Chole Calciferol and
Cynocobalamine Injections ·
Sodium Acid Phosphate
Injections (6) Veterinary
Injections ·
Dexamethasone Sodium Phosphate
Injections ·
Pheniramine Maleate
Injections ·
Methyl Ergometrine
Maleate Injections ·
Hydroxy Progesterone
Caproate Injections ·
Frusemide Injections ·
Atropine Sulphate
Injections ·
Ivermectin Injections ·
Levamisole Injections (7) Veterinary
Feed Supplements ·
Tri basic Calcium and
Vit D 3 + Vit B.12 ·
Oral Formulation Of
Vitamins And Minerals Human Products ·
Sterile Sulbactam and
Cefoperazone Injections ·
Clavulanate Potassium
and Amoxycillin Injections ·
Sterile Ceftazidime
Injections ·
Sterile Cefotaxime Injections ·
Sterile Ceftriaxone
Injections ·
Sterile Ceftriaxone and
Sterile Sulbactam Injections ·
Sterile Ceftriaxone and
Sterile Tazobactam Injections ·
Ampicillin and
Cloxacillin Injections ·
Amikacin Sulphate
Injections ·
Gentamicin Sulphate
Injections ·
Dexamethasone Phosphate
Injections ·
Nandrolone Decanoate
Injections ·
2-Pyridine Aldoxime
Methiodide Injections ·
Ondansetron Injections ·
α β Arteether
Injections. |
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit |
|
|
|
|
Purchasing : |
Cash and Credit |
PRODUCTION STATUS (As on 31.03.2011)
|
Particulars |
|
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
Generic Products And Veterinary Products |
|
NA |
13500000
Vials |
3427728Vials |
GENERAL INFORMATION
|
Customers : |
·
Wholesalers ·
Retailers |
|||||||||||||||
|
|
|
|||||||||||||||
|
No. of Employees : |
50 (Approximately) |
|||||||||||||||
|
|
|
|||||||||||||||
|
Bankers : |
·
Bank of Baroda, Mehsana Highway Branch, Gujarat,
India ·
The Mehsana Nagrik Sahakari Bank Limited, Near Arvind Baugh, Opposite, Sarvajanik
Kanya Vidhyalaya, Mehsana – 384001, Gujarat, India ·
The
Visnagar Nagrik Sahakari Bank Limited, Visnagar ·
Mehsana Urban Co-Operative Bank Limited ·
Sarvoday Nagrik Sahakari Bank Limited ·
Dena Bank, Mehsana ·
Dena Bank, Mumbai ·
Sarvoday Commercial Co-Operative Bank Limited ·
The Mehsana Dist. Cent. Co-Operative Bank
Limited |
|||||||||||||||
|
|
|
|||||||||||||||
|
Facilities : |
(Rs. in Millions)
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Babulal Patel and Company Chartered Accountants |
|
Address : |
2nd Floor, A/10 and 11, Ajanta Commercial Centre, Near
Income Tax Office, Ashram Road, Ahmedabad – 380014, Gujarat, India |
|
Tel. No.: |
91-79-27540268 (O) / 27540268 / 27640806 (R) |
|
PAN.: |
ABCPP5322K |
CAPITAL STRUCTURE
As on 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000 |
Equity Shares |
Rs.100/- each |
Rs.1.500 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13000 |
Equity Shares |
Rs.100/-
each |
Rs.1.300
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
1.300 |
1.300 |
1.300 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1.524 |
2.095 |
1.958 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
2.824 |
3.395 |
3.258 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
9.093 |
9.240 |
8.609 |
|
|
TOTAL BORROWING |
9.093 |
9.240 |
8.609 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.122 |
0.152 |
|
|
|
|
|
|
|
|
TOTAL |
11.917 |
12.757 |
12.019 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
6.546 |
5.170 |
5.701 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
1.101 |
1.101 |
1.101 |
|
|
DEFERREX TAX ASSETS |
0.079 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
4.970
|
4.547
|
5.831
|
|
|
Sundry Debtors |
6.135
|
11.875
|
16.206
|
|
|
Cash & Bank Balances |
2.443
|
2.554
|
1.814
|
|
|
Other Current Assets |
0.000
|
0.000
|
0.000
|
|
|
Loans & Advances |
2.418
|
2.024
|
1.226
|
|
Total
Current Assets |
15.966
|
21.000
|
25.077
|
|
|
Less : CURRENT LIABILITIES
& PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
8.060
|
11.816
|
17.551
|
|
|
Other Current Liabilities |
3.074
|
2.057
|
1.751
|
|
|
Provisions |
0.641
|
0.641
|
0.558
|
|
Total
Current Liabilities |
11.775
|
14.514
|
19.860
|
|
|
Net Current Assets |
4.191
|
6.486
|
5.217
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
11.917 |
12.757 |
12.019 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
35.084 |
39.651 |
36.086 |
|
|
|
Other Income |
0.026 |
0.024 |
0.015 |
|
|
|
TOTAL (A) |
35.110 |
39.675 |
36.101 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Manufacturing Expenses |
27.580 |
31.165 |
25.036 |
|
|
|
Purchase of goods traded in |
0.149 |
0.212 |
0.890 |
|
|
|
Employees remuneration and benefits |
2.477 |
2.322 |
2.037 |
|
|
|
General, Administrative Expenses |
0.903 |
0.930 |
1.616 |
|
|
|
Selling and Distribution Expenses |
3.304 |
3.431 |
4.119 |
|
|
|
Increase / Decrease in Stock |
0.218 |
(0.154) |
(0.239) |
|
|
|
TOTAL (B) |
34.631 |
37.906 |
33.459 |
|
|
|
|
|
|
|
|
Less |
PROFIT/(LOSS)
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
0.479 |
1.769 |
2.642 |
|
|
|
|
|
|
|
|
|
Less |
INTEREST AND
FINANCIAL CHARGES (D) |
0.531 |
0.815 |
0.687 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION
(C-D) (E) |
(0.052) |
0.954 |
1.955 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
0.721 |
0.719 |
0.825 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE TAX (E-F) (G) |
(0.773) |
0.235 |
1.130 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
0.201 |
0.097 |
0.472 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) AFTER TAX (G-H) (I) |
(0.572) |
0.138 |
0.658 |
|
|
|
|
|
|
|
|
|
|
Earnings/(Loss)
Per Share (Rs.) |
(43.97) |
10.59 |
50.59 |
|
|
Particulars |
|
|
31.03.2012 |
|
Sales Turnover (Approximately) |
|
|
50.000 |
Expected Sales (2012-2013): Rs.60.000 Millions
The above information has been parted by Mr. Kalpesh – Accounts
Department
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
(16.29)
|
0.35
|
1.82
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
(2.20)
|
0.59
|
3.13
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(4.84)
|
0.90
|
3.67
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.27)
|
0.07
|
0.35
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
7.39
|
7.00
|
8.74
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
1.45
|
1.26
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Yes |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
32] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
BANKERS CHARGES
REPORT AS PER REGISTRY
|
Corporate
identity number of the company |
U24231GJ1983PTC006187 |
|
Name of the
company |
MORVER
LABORATORIES PRIVATE LIMITED |
|
Address of the registered
office or of the principal place of
business in India of the company |
25,
Jawahar Nagar Society, Visnagar, District Mehsana – 382 010, Gujarat, India Email:
info@morvellab.com |
|
This form is for
|
Creation of charge |
|
Type of charge |
Movable property
(not being pledge) |
|
Particular of
charge holder |
The Mehsana Nagrik Sahakari Bank Limited, Near Arvind Baugh, Opposite,
Sarvajanik Kanya Vidhyalaya, Mehsana – 384001, Gujarat, India Email: mnsbho@gmail.com |
|
Nature of
instrument creating charge |
Letter of
hypothecation of vehicle |
|
Date of
instrument Creating the charge |
10.11.2011 |
|
Amount secured
by the charge |
Rs.1.000 Million |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of Interest 11% per annum Terms of Repayment The loan of Rs.1.000 million is to be paid by 48 equal monthly
instalments of Rs.0.020 Million each. The first of such instalment is to be
payable on 15th December, 2011. Margin Rs.0.357 Million Extent and Operation of the charge Hypothecation of chevrolet cruze car |
|
Short
particulars of the property or asset(s) charged (including complete address and
location of the property) |
Chevrolet Cruze
Car |
CONTINGENT LIABILITIES
|
Particulars |
As on 31.03.2011 Rs. in millions |
|
Guarantee issued by banks |
0.219 |
FIXED ASSETS
·
·
Building
·
Plant and Machinery
·
Electric Installation
·
Laboratory Equipment
·
Office Equipment
·
Furniture and Fixtures
·
Vehicles
·
Computer
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.70 |
|
|
1 |
Rs.87.54 |
|
Euro |
1 |
Rs.68.85 |
INFORMATION DETAILS
|
Information
Gathered by : |
PJA |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
27 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.